Classification of current anticancer immunotherapies

Author:

Galluzzi Lorenzo1234,Vacchelli Erika123,Pedro José-Manuel Bravo-San123,Buqué Aitziber123,Senovilla Laura123,Baracco Elisa Elena1235,Bloy Norma1235,Castoldi Francesca12356,Abastado Jean-Pierre7,Agostinis Patrizia8,Apte Ron N.9,Aranda Fernando12310,Ayyoub Maha1112,Beckhove Philipp13,Blay Jean-Yves1415,Bracci Laura16,Caignard Anne1718,Castelli Chiara19,Cavallo Federica20,Celis Estaban21,Cerundolo Vincenzo22,Clayton Aled2324,Colombo Mario P.19,Coussens Lisa25,Dhodapkar Madhav V.26,Eggermont Alexander M.3,Fearon Douglas T.27,Fridman Wolf H.242829,Fučíková Jitka630,Gabrilovich Dmitry I.31,Galon Jérôme242832,Garg Abhishek8,Ghiringhelli François333435,Giaccone Giuseppe3637,Gilboa Eli38,Gnjatic Sacha39,Hoos Axel40,Hosmalin Anne4414243,Jäger Dirk44,Kalinski Pawel454647,Kärre Klas48,Kepp Oliver1249,Kiessling Rolf50,Kirkwood John M.51,Klein Eva48,Knuth Alexander52,Lewis Claire E.53,Liblau Roland545556,Lotze Michael T.4546,Lugli Enrico57,Mach Jean-Pierre58,Mattei Fabrizio16,Mavilio Domenico5759,Melero Ignacio6061,Melief Cornelis J.6263,Mittendorf Elizabeth A.64,Moretta Lorenzo65,Odunsi Adekunke66,Okada Hideho67,Palucka Anna Karolina68,Peter Marcus E.69,Pienta Kenneth J.70,Porgador Angel9,Prendergast George C.717273,Rabinovich Gabriel A.74,Restifo Nicholas P.75,Rizvi Naiyer76,Sautès-Fridman Catherine242829,Schreiber Hans77,Seliger Barbara78,Shiku Hiroshi79,Silva-Santos Bruno80,Smyth Mark J.8182,Speiser Daniel E.8384,Spisek Radek630,Srivastava Pramod K.8586,Talmadge James E.87,Tartour Eric4888990,Van Der Burg Sjoerd H.91,Van Den Eynde Benoît J.929394,Vile Richard95,Wagner Hermann96,Weber Jeffrey S.97,Whiteside Theresa L.4698,Wolchok Jedd D.99100,Zitvogel Laurence3101102,Zou Weiping103,Kroemer Guido12449104

Affiliation:

1. Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France

2. INSERM, U1138, Paris, France

3. Gustave Roussy Cancer Campus, Villejuif, France

4. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France

5. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France

6. Sotio a.c., Prague, Czech Republic

7. Pole d'innovation thérapeutique en oncologie, Institut de Recherches Internationales Servier, Suresnes, France

8. Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium

9. The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

10. Group of Immune receptors of the Innate and Adaptive System, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

11. INSERM, U1102, Saint Herblain, France

12. Institut de Cancérologie de l'Ouest, Saint Herblain, France

13. Translational Immunology Division, German Cancer Research Center, Heidelberg, Germany

14. Equipe 11, Centre Léon Bérard (CLR), Lyon, France

15. Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France

16. Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy

17. INSERM, U1160, Paris, France

18. Groupe Hospitalier Saint Louis-Lariboisière - F. Vidal, Paris, France

19. Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

20. Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

21. Cancer Immunology, Inflammation and Tolerance Program, Georgia Regents University Cancer Center, Augusta, GA, USA

22. MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK

23. Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK

24. Velindre Cancer Centre, Cardiff, UK

25. Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

26. Sect. of Hematology and Immunobiology, Yale Cancer Center, Yale University, New Haven, CT, USA

27. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA

28. Université Pierre et Marie Curie/Paris VI, Paris, France

29. Equipe 13, Centre de Recherche des Cordeliers, Paris, France

30. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic

31. Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

32. Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France

33. INSERM, UMR866, Dijon, France

34. Centre Georges François Leclerc, Dijon, France

35. Université de Bourgogne, Dijon, France

36. Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA

37. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA

38. Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA

39. Sect. of Hematology/Oncology, Immunology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

40. Glaxo Smith Kline, Cancer Immunotherapy Consortium, Collegeville, PA, USA

41. INSERM, U1016, Paris, France

42. CNRS, UMR8104, Paris, France

43. Hôpital Cochin, AP-HP, Paris, France

44. National Center for Tumor Diseases, University Medical Center Heidelberg, Heidelberg, Germany

45. Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA

46. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA

47. Dept. of Immunology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA

48. Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden

49. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France

50. Dept. of Oncology, Karolinska Institute Hospital, Stockholm, Sweden

51. University of Pittsburgh Cancer Institute Laboratory, Pittsburgh, PA, USA

52. National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

53. Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology, University of Sheffield Medical School, Sheffield, UK

54. INSERM, UMR1043, Toulouse, France

55. CNRS, UMR5282, Toulouse, France

56. Laboratoire d'Immunologie, CHU Toulouse, Université Toulouse II, Toulouse, France

57. Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy

58. Dept. of Biochemistry, University of Lausanne, Epalinges, Switzerland

59. Dept. of Medical Biotechnologies and Translational Medicine, University of Milan, Rozzano, Italy

60. Dept. of Immunology, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

61. Dept. of Oncology, Clínica Universidad de Navarra, Pamplona, Spain

62. ISA Therapeutics, Leiden, The Netherlands

63. Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

64. Research Dept. of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

65. Istituto Giannina Gaslini, Genova, Italy

66. Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA

67. Dept. of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA

68. The Jackson Laboratory for Genomics Medicine, Farmington, CT, USA

69. Div. of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

70. The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

71. Lankenau Institute for Medical Research, Wynnewood, PA, USA

72. Dept. of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Philadelphia, PA, USA

73. Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

74. Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Buenos Aires, Argentina

75. National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA

76. Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA

77. Dept. of Pathology, The Cancer Research Center, The University of Chicago, Chicago, IL, USA

78. Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany

79. Dept. of Immuno-GeneTherapy, Mie University Graduate School of Medicine, Tsu, Japan

80. Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal

81. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

82. School of Medicine, University of Queensland, Herston, Queensland, Australia

83. Dept. of Oncology, University of Lausanne, Lausanne, Switzerland

84. Ludwig Cancer Research Center, Lausanne, Switzerland

85. Dept. of Immunology, University of Connecticut School of Medicine, Farmington, CT, USA

86. Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, USA

87. Laboratory of Transplantation Immunology, Dept. of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

88. INSERM, U970, Paris, France

89. Paris-Cardiovascular Research Center (PARCC), Paris, France

90. Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France

91. Dept. of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands

92. Ludwig Institute for Cancer Research, Brussels, Belgium

93. de Duve Institute, Brussels, Belgium

94. Université Catholique de Louvain, Brussels, Belgium

95. Dept. of Molecular Medicine and Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA

96. Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany

97. Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, FL, USA

98. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

99. Dept. of Medicine and Ludwig Center, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA

100. Weill Cornell Medical College, New York, NY, USA

101. INSERM, U1015, Villejuif, France

102. Centre d'Investigation Clinique Biothérapie 507 (CICBT507), Gustave Roussy Cancer Campus, Villejuif, France

103. University of Michigan, School of Medicine, Ann Arbor, MI, USA

104. Pôle de Biologie, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 361 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3